Healthy Skepticism Library item: 3408
Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.
 
Publication type: Journal Article
Re: the promotion of amidopyrine/phenylbutazone/prednisolone
1986 Dec;
Abstract:
Scanpharm is marketing a combination of amidopyrine and phenylbutazone and prednisolone in Fiji for a variety of musculoskeletal problems. MaLAM has questions about the safety of amidopyrine and about the effectiveness of this combination.
Keywords:
*analysis/Fiji/developing countries/Scanpharm/amidopyrine/phenylbutazone/prednisolone/MaLAM/Medical Lobby for Appropriate Marketing/ quality of information/ safety & risk information/EVALUATION OF PROMOTION: DRUG SAFETY/PROMOTION AND HEALTH NEEDS: PROMOTION IN DEVELOPING COUNTRIES